Kake is a press release distribution service. On Nov 29, 2019, it released an article on the Hypolipidemic Drugs Global Market, sourced from TBRC`S Hypolipidemic Drugs Global Market Report. The global hypolipidemics market was valued at about $10.1 billion in 2018. The hypolipidemic drugs industry includes establishments that produce hypolipidemic drugs or agents that lower lipid and lipoproteins levels in the blood. These drugs can be used to prevent cardiovascular diseases and atherosclerosis in Hyperlipidemia patients. Some of the major hypolipidemic drugs include fibric acid derivatives, bile acid binding resins, nicotinamides, and cholesterol absorption inhibitors.